Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.

Anderson SM, Buckingham BA, Breton MD, Robic JL, Barnett CL, Wakeman CA, Oliveri MC, Brown SA, Ly TT, Clinton PK, Hsu LJ, Kingman RS, Norlander LM, Loebner SE, Reuschel-DiVirglio S, Kovatchev BP.

Diabetes Technol Ther. 2019 Jun;21(6):356-363. doi: 10.1089/dia.2019.0018. Epub 2019 May 16.

PMID:
31095423
2.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.

Forlenza GP, Buckingham BA, Christiansen MP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 May;21(5):265-272. doi: 10.1089/dia.2019.0017. Epub 2019 Mar 29.

3.

Outage Performance Analysis and SWIPT Optimization in Energy-Harvesting Wireless Sensor Network Deploying NOMA.

Nguyen HS, Ly TTH, Nguyen TS, Huynh VV, Nguyen TL, Voznak M.

Sensors (Basel). 2019 Feb 1;19(3). pii: E613. doi: 10.3390/s19030613.

4.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.

Adams RN, Tanenbaum ML, Hanes SJ, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

Diabetes Technol Ther. 2018 Oct;20(10):648-653. doi: 10.1089/dia.2018.0174. Epub 2018 Sep 21.

PMID:
30239219
5.

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age.

Ly TT, Layne JE, Huyett LM, Nazzaro D, O'Connor JB.

J Diabetes Sci Technol. 2019 Jan;13(1):20-26. doi: 10.1177/1932296818798836. Epub 2018 Sep 21.

PMID:
30239214
6.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Buckingham BA, Christiansen MP, Forlenza GP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

7.

FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.

Gurzau AD, Chen K, Xue S, Dai W, Lucet IS, Ly TTN, Reversade B, Blewitt ME, Murphy JM.

J Biol Chem. 2018 Jun 22;293(25):9841-9853. doi: 10.1074/jbc.RA118.003104. Epub 2018 May 10.

8.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Forlenza GP, Cameron FM, Ly TT, Lam D, Howsmon DP, Baysal N, Kulina G, Messer L, Clinton P, Levister C, Patek SD, Levy CJ, Wadwa RP, Maahs DM, Bequette BW, Buckingham BA.

Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.

9.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.

10.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.

Howsmon DP, Baysal N, Buckingham BA, Forlenza GP, Ly TT, Maahs DM, Marcal T, Towers L, Mauritzen E, Deshpande S, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Dassau E, Hahn J, Bequette BW.

J Diabetes Sci Technol. 2018 May;12(3):599-607. doi: 10.1177/1932296818755173. Epub 2018 Feb 1.

11.

Calcification of the epiglottis presenting as foreign body sensation in the neck.

Jeph S, Aidi M, Shah A, Ly TT, Bronov O.

J Radiol Case Rep. 2017 Jun 30;11(6):1-5. doi: 10.3941/jrcr.v11i6.3093. eCollection 2017 Jun.

12.

The Importance of the Hawthorne Effect on Psychological Outcomes Unveiled in a Randomized Controlled Trial of Diabetes Technology.

Abraham MB, Nicholas JA, Crone M, Ly TT, Davis EA, Jones TW.

J Diabetes Sci Technol. 2018 May;12(3):735-736. doi: 10.1177/1932296817747293. Epub 2017 Dec 25. No abstract available.

13.

A Comparison of Fucoidan Conjugated to Paclitaxel and Curcumin for the Dual Delivery of Cancer Therapeutic Agents.

Phan NH, Ly TT, Pham MN, Luu TD, Vo TV, Tran PHL, Tran TTD.

Anticancer Agents Med Chem. 2018;18(9):1349-1355. doi: 10.2174/1871520617666171121125845.

PMID:
29173183
14.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA; In-Home Closed-Loop (IHCL) Study Group.

Pediatr Diabetes. 2018 May;19(3):420-428. doi: 10.1111/pedi.12603. Epub 2017 Nov 20.

15.

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 8. No abstract available.

16.

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users.

Tanenbaum ML, Iturralde E, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

J Health Psychol. 2017 Jul 1:1359105317718615. doi: 10.1177/1359105317718615. [Epub ahead of print]

PMID:
28810490
17.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW.

Diabetes Technol Ther. 2017 Sep;19(9):527-532. doi: 10.1089/dia.2017.0078. Epub 2017 Aug 2.

18.

Atomistic study of the alloying behavior of crystalline SnSe1-xSx.

Ly TT, Duvjir G, Min T, Byun J, Kim T, Saad MM, Hai NTM, Cho S, Lee J, Kim J.

Phys Chem Chem Phys. 2017 Aug 16;19(32):21648-21654. doi: 10.1039/c7cp03481d.

PMID:
28766639
19.

Reproducibility of the plasma glucose response to moderate-intensity exercise in adolescents with Type 1 diabetes.

Abraham MB, Davey RJ, Cooper MN, Paramalingam N, O'Grady MJ, Ly TT, Jones TW, Fournier PA, Davis EA.

Diabet Med. 2017 Sep;34(9):1291-1295. doi: 10.1111/dme.13395. Epub 2017 Jul 14.

PMID:
28586529
20.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Aug;40(8):1096-1102. doi: 10.2337/dc17-0500. Epub 2017 Jun 5. Erratum in: Diabetes Care. 2017 Sep 8;:.

21.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ 3rd, Pinsker JE, Maahs DM, Buckingham BA, Dassau E.

Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1.

22.

Improvement of a P450-Based Recombinant Escherichia coli Whole-Cell System for the Production of Oxygenated Sesquiterpene Derivatives.

Ly TTB, Schifrin A, Nguyen BD, Bernhardt R.

J Agric Food Chem. 2017 May 17;65(19):3891-3899. doi: 10.1021/acs.jafc.7b00792. Epub 2017 May 4.

PMID:
28447451
23.

Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System.

Iturralde E, Tanenbaum ML, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK.

Diabetes Educ. 2017 Apr;43(2):223-232. doi: 10.1177/0145721717697244.

PMID:
28340542
24.

Evaluation of a Predictive Low-Glucose Management System In-Clinic.

Buckingham BA, Bailey TS, Christiansen M, Garg S, Weinzimer S, Bode B, Anderson SM, Brazg R, Ly TT, Kaufman FR.

Diabetes Technol Ther. 2017 May;19(5):288-292. doi: 10.1089/dia.2016.0319. Epub 2017 Feb 16.

PMID:
28221823
25.

Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.

Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT; In-Home Closed-Loop (IHCL) Study Group.

Diabetes Care. 2017 Mar;40(3):359-366. doi: 10.2337/dc16-1794. Epub 2017 Jan 18.

26.

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs).

Howsmon DP, Cameron F, Baysal N, Ly TT, Forlenza GP, Maahs DM, Buckingham BA, Hahn J, Bequette BW.

Sensors (Basel). 2017 Jan 15;17(1). pii: E161. doi: 10.3390/s17010161.

27.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Kovatchev B, Cheng P, Anderson SM, Pinsker JE, Boscari F, Buckingham BA, Doyle FJ 3rd, Hood KK, Brown SA, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Ly TT, Shanmugham S, Dassau E, Kollman C, Lum JW, Beck RW.

Diabetes Technol Ther. 2017 Jan;19(1):18-24. doi: 10.1089/dia.2016.0333. Epub 2016 Dec 16.

PMID:
27982707
28.

Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.

Cescon M, DeSalvo DJ, Ly TT, Maahs DM, Messer LH, Buckingham BA, Doyle FJ 3rd, Dassau E.

J Diabetes Sci Technol. 2016 Nov 1;10(6):1268-1276. Print 2016 Nov.

29.

Structural insights into the interaction of human p97 N-terminal domain and SHP motif in Derlin-1 rhomboid pseudoprotease.

Lim JJ, Lee Y, Yoon SY, Ly TT, Kang JY, Youn HS, An JY, Lee JG, Park KR, Kim TG, Yang JK, Jun Y, Eom SH.

FEBS Lett. 2016 Dec;590(23):4402-4413. doi: 10.1002/1873-3468.12447. Epub 2016 Oct 21.

30.

Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.

Abraham MB, Davey R, O'Grady MJ, Ly TT, Paramalingam N, Fournier PA, Roy A, Grosman B, Kurtz N, Fairchild JM, King BR, Ambler GR, Cameron F, Jones TW, Davis EA.

Diabetes Technol Ther. 2016 Sep;18(9):543-50. doi: 10.1089/dia.2016.0141. Epub 2016 Aug 9.

PMID:
27505305
31.

Structural insights into the interaction of p97 N-terminus domain and VBM in rhomboid protease, RHBDL4.

Lim JJ, Lee Y, Ly TT, Kang JY, Lee JG, An JY, Youn HS, Park KR, Kim TG, Yang JK, Jun Y, Eom SH.

Biochem J. 2016 Sep 15;473(18):2863-80. doi: 10.1042/BCJ20160237. Epub 2016 Jul 12.

PMID:
27407164
32.

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp.

Ly TT, Buckingham BA, DeSalvo DJ, Shanmugham S, Satin-Smith M, DeBoer MD, Oliveri MC, Schertz E, Breton MD, Cherñavvsky DR.

Diabetes Care. 2016 Aug;39(8):e106-7. doi: 10.2337/dc16-0817. Epub 2016 Jun 6. No abstract available.

33.

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.

Karlin AW, Ly TT, Pyle L, Forlenza GP, Messer L, Wadwa RP, DeSalvo DJ, Payne SL, Hanes S, Clinton P, Maahs DM, Buckingham B.

Diabetes Technol Ther. 2016 Jul;18(7):429-35. doi: 10.1089/dia.2015.0432. Epub 2016 May 26.

34.

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days.

DeSalvo DJ, Ly TT, Wadwa RP, Messer L, Westfall E, Gopisetty D, Hanes S, von Eyben R, Maahs DM, Buckingham BA.

Diabetes Care. 2016 Aug;39(8):e112-3. doi: 10.2337/dc16-0796. Epub 2016 May 23. No abstract available.

35.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

36.

Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.

Ly TT, Weinzimer SA, Maahs DM, Sherr JL, Roy A, Grosman B, Cantwell M, Kurtz N, Carria L, Messer L, von Eyben R, Buckingham BA.

Pediatr Diabetes. 2017 Aug;18(5):348-355. doi: 10.1111/pedi.12399. Epub 2016 May 18.

PMID:
27191182
37.

Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp.

Ly TT, Keenan DB, Roy A, Han J, Grosman B, Cantwell M, Kurtz N, von Eyben R, Clinton P, Wilson DM, Buckingham BA.

Diabetes Technol Ther. 2016 Jun;18(6):377-84. doi: 10.1089/dia.2015.0431. Epub 2016 May 16.

PMID:
27183197
38.

Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.

Abraham MB, de Bock M, Paramalingam N, O'Grady MJ, Ly TT, George C, Roy A, Spital G, Karula S, Heels K, Gebert R, Fairchild JM, King BR, Ambler GR, Cameron F, Davis EA, Jones TW.

Diabetes Technol Ther. 2016 Jul;18(7):436-43. doi: 10.1089/dia.2015.0364. Epub 2016 May 5.

PMID:
27148807
39.

In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.

Messer LH, Calhoun P, Buckingham B, Wilson DM, Hramiak I, Ly TT, Driscoll M, Clinton P, Maahs DM; In Home Closed Loop Study Group.

Pediatr Diabetes. 2017 Aug;18(5):332-339. doi: 10.1111/pedi.12395. Epub 2016 Apr 29.

40.

Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function.

Abraham MB, Nicholas JA, Ly TT, Roby HC, Paramalingam N, Fairchild J, King BR, Ambler GR, Cameron F, Davis EA, Jones TW.

BMJ Open. 2016 Apr 15;6(4):e011589. doi: 10.1136/bmjopen-2016-011589.

41.

New Sesquiterpene Oxidations with CYP260A1 and CYP264B1 from Sorangium cellulosum So ce56.

Schifrin A, Litzenburger M, Ringle M, Ly TT, Bernhardt R.

Chembiochem. 2015 Dec;16(18):2624-32. doi: 10.1002/cbic.201500417. Epub 2015 Nov 10.

PMID:
26449371
42.

Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes.

DeSalvo DJ, Maahs DM, Messer L, Wadwa RP, Payne S, Ly TT, Buckingham BA.

Diabetes Care. 2015 Oct;38(10):e166-7. doi: 10.2337/dc15-1267. Epub 2015 Aug 25. No abstract available.

43.

Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.

Ly TT, Roy A, Grosman B, Shin J, Campbell A, Monirabbasi S, Liang B, von Eyben R, Shanmugham S, Clinton P, Buckingham BA.

Diabetes Care. 2015 Jul;38(7):1205-11. doi: 10.2337/dc14-3073. Epub 2015 Jun 6.

44.

A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: a study protocol.

Thompson CN, Anders KL, Nhi le TQ, Tuyen HT, Van Minh P, Tu le TP, Nhu Tdo H, Nhan NT, Ly TT, Duong VT, Vi LL, Van Thuy NT, Hieu NT, Van Chau NV, Campbell JI, Thwaites G, Simmons C, Baker S.

BMC Public Health. 2014 Dec 17;14:1289. doi: 10.1186/1471-2458-14-1289.

45.

Characterization of the gene cluster CYP264B1-geoA from Sorangium cellulosum So ce56: biosynthesis of (+)-eremophilene and its hydroxylation.

Schifrin A, Ly TT, Günnewich N, Zapp J, Thiel V, Schulz S, Hannemann F, Khatri Y, Bernhardt R.

Chembiochem. 2015 Jan 19;16(2):337-44. doi: 10.1002/cbic.201402443. Epub 2014 Dec 12.

PMID:
25504914
46.

The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.

Stenerson M, Cameron F, Payne SR, Payne SL, Ly TT, Wilson DM, Buckingham BA.

J Diabetes Sci Technol. 2015 Jan;9(1):80-5. doi: 10.1177/1932296814551045. Epub 2014 Sep 17.

47.

A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.

Ly TT, Brnabic AJ, Eggleston A, Kolivos A, McBride ME, Schrover R, Jones TW.

Value Health. 2014 Jul;17(5):561-9. doi: 10.1016/j.jval.2014.05.008. Epub 2014 Jul 15.

48.

ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes.

Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW; International Society for Pediatric and Adolescent Diabetes.

Pediatr Diabetes. 2014 Sep;15 Suppl 20:180-92. doi: 10.1111/pedi.12174. Epub 2014 Jul 12. No abstract available.

PMID:
25040141
49.

Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.

Ly TT, Breton MD, Keith-Hynes P, De Salvo D, Clinton P, Benassi K, Mize B, Chernavvsky D, Place J, Wilson DM, Kovatchev BP, Buckingham BA.

Diabetes Care. 2014 Aug;37(8):2310-6. doi: 10.2337/dc14-0147. Epub 2014 May 30.

50.

Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control.

DeSalvo DJ, Shanmugham S, Ly TT, Wilson DM, Buckingham BA.

J Diabetes Sci Technol. 2014 Sep;8(5):969-73. doi: 10.1177/1932296814532238. Epub 2014 May 21.

Supplemental Content

Support Center